Close Menu

NEW YORK – Natera has priced a follow-on offering of its common stock at $35 per share, the San Carlos, California-based molecular diagnostics firm announced this morning.

Natera is offering 5,714,286 shares of its common stock, which would result in gross proceeds of $200 million. If the underwriters exercise their option to an additional 857,142 shares of Natera's common stock, that would bring in an additional $30 million in gross proceeds.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.